Tirzepatide injections + B6

Non Salt Form

Tirzepatide are approved GLP-1 agonist medications used to treat obesity and aid in dramatic weight loss. Tirzepatide are both once-weekly injections that require no change in diet or lifestyle to produce weight loss results of greater than 50 lb in as little as 6 months. When used along with an individualized low-calorie, low-carb diet, and exercise program to help with weight loss, overweight adults who may also have high blood pressure, diabetes, or high cholesterol see significant progress across all health markers. Tirzepatide injections are a class of medications called glucagon-like-peptide-1 (GLP-1) agonists, although tirzepatide has enhanced effects as a glucose-dependent insulinotropic polypeptide (GIP) agonist that produce more drastic weight loss results.

Tirzepatide works by stimulating both GLP-1 and glucagon receptors on pancreatic beta cells, which leads to increased insulin release into the bloodstream. In clinical trials, tirzepatide Therapy was found to be safe and effective for reducing HbA1c levels by up to 1.7%.

Tirzepatide Therapy also has been proven to improve beta cell function and reduce fasting plasma glucose levels compared with placebo. Additionally, tirzepatide therapy has been found to lower triglycerides and non-HDL cholesterol levels while increasing HDL cholesterol levels in diabetic patients. Tirzepatide Therapy may offer a unique advantage over other treatments for diabetes as it can be used alone or in combination with existing medications such as metformin or sulfonylureas.

The dual receptor agonism of tirzepatide Therapy allows for greater control over insulin secretion and glycemic control without the additional risk of hypoglycemia or weight gain typically associated with traditional therapies. Tirzepatide Therapy has quickly become a promising option for those looking for an effective way to manage their weight and better their health.


How does tirzepatide contribute to weight loss?
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by regulating insulin and glucagon, leading to reduced appetite, delayed gastric emptying, and improved glucose control, all contributing to weight loss.

What is the recommended dosage of tirzepatide for weight loss?
Dosages of tirzepatide for weight loss vary and are determined based on individual factors. Healthcare providers will prescribe an appropriate dosage, often titrated up gradually to achieve optimal results while minimizing potential side effects.

How much weight will I lose?
Your weight loss depends on many biologic factors including the duration and dosages that you receive. While individual results may vary, customers may potentially achieve weight loss targets of up to 30 pounds in the first three months of treatment, and possibly 50 pounds after 6 months. In a 72-week trial in participants with obesity, 5 mg, 10 mg, or 15 mg of tirzepatide once weekly provided substantial and sustained reductions in body weight of up to 20%.

How should this medicine be used?
Tirzepatide comes in the form of a sterile liquid solution that is administered via subcutaneous injection once a week. It starts with a titrate to reduce side effects.

Starting Dose starts at $400 per month
Highest Dose at 15 MG is $400 per month
(most patients never go above 10 Milligrams)

Who Shouldn't Use tirzepatide?
Given the theoretical risk, tirzepatide should be avoided in those with a personal or family history of medullary thyroid carcinoma. Patients with a history of MEN 2 (multiple endocrine neoplasia syndrome type-2) should also avoid tirzepatide.

Contact Us

One Peak Medical Care